Blog

‌NCCN Clinical Practice Guidelines: B-Cell Lymphomas (2024.V2)

Follicular Lymphoma (FL)‌ ‌Third-Line and Beyond Therapy:‌ ‌T-cell engager bispecific antibodies:‌ Added ‌epcoritamab-bysp‌ as a ‌Category 2A‌ preferred recommendation. ‌CAR-T cell therapy:‌ Added ‌lisocabtagene maraleucel‌ (CD19-targeted) as a ‌Category 2A‌…

Read More

NCCN Clinical Practice Guidelines: Systemic Mastocytosis

Updates to Treatment Protocols‌ ‌Second-Line Therapy for Bone Pain‌ For patients unresponsive to bisphosphonates or those with renal insufficiency contraindicated for bisphosphonates, ‌anti-RANKL monoclonal antibodies (e.g., denosumab)‌ are recommended. FDA-approved…

Read More

‌Special Precautions for Medication Use

‌1. Medications Requiring Increased Water Intake‌ ‌Bronchodilators‌: Theophylline, aminophylline, diprophylline. ‌Choleretics‌: Phenylpropanol, hymecromone, dehydrocholic acid, ursodeoxycholic acid. ‌Protease Inhibitors‌: Ritonavir, indinavir, nelfinavir, amprenavir, lopinavir. ‌Bisphosphonates‌: Alendronate, pamidronate, clodronate. ‌Antigout Agents‌:…

Read More

Uterine Factors Contributing to Infertility

The uterus plays a critical role in supporting conception and pregnancy. Successful embryo implantation and fetal development depend on a healthy uterine environment. Below are key uterine factors that can…

Read More